Maitland, M L <br/><br/>
Estimation of renal cell carcinoma treatment effects from disease progression modeling.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Apr 2013 
 - 345-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Validation Study 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1038/clpt.2012.263  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Renal Cell--drug therapy<br/>Clinical Trials, Phase II as Topic--statistics & numerical data<br/>Clinical Trials, Phase III as Topic--statistics & numerical data<br/>Disease Progression<br/>Kidney Neoplasms--drug therapy<br/>Models, Statistical<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds--therapeutic use<br/>Sorafenib